Evidence map›Paper›PMID 24789326›Full record

ReviewPLoS pathogens2014

PARV4: an emerging tetraparvovirus.

Philippa C Matthews, Amna Malik, Ruth Simmons, Colin Sharp, Peter Simmonds, Paul Klenerman

Abstract readReview
In one paragraph

Review in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Gastroenterology and hepatology from bed to bench · 2018
    Article
  7. Article
  8. Review
  9. Human Parvoviruses.Clinical microbiology reviews · 2017
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Philippa C MatthewsNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, Oxford, United Kingdom; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Oxford, United Kingdom.
Amna MalikDepartment of Paediatrics, Peter Medawar Building for Pathogen Research, Oxford, United Kingdom.
Ruth SimmonsNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, Oxford, United Kingdom.
Colin SharpThe Roslin Institute, The University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom.
Peter SimmondsThe Roslin Institute, The University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom.
Paul KlenermanNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, Oxford, United Kingdom; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Oxford, United Kingdom; NIHR Biomedical Research Centre, John Radcliffe Hospital, Headington, Oxford, United Kingdom.

Funding

Wellcome Trust 091663Wellcome Trust 095831Wellcome Trust MA091663
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCommunicable Diseases, EmergingHumansParvoviridae InfectionsParvovirusVirus Latency

Identifiers

PMID24789326
PMCPMC4006886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.